In this review:
Adalimumab maintenance regimens in UC
Tofacitinib in UC
Intestinal ultrasound response/transmural healing after ustekinumab in CD
Ustekinumab vs vedolizumab in CD with prior anti-TNF failure
Pregnancy outcomes with ustekinumab for UC
Combining biological therapies together or with small molecules
Early ileocaecal resection for CD
Long-term outcomes after ileocolonic resection in CD
Surgical prevention of anastomotic recurrence in CD
Colorectal cancer diagnosis/mortality in CD
Please login below to download this issue (PDF)